Linked Life Data

10365143

Source:http://linkedlifedata.com/resource/pubmed/id/10365143

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2C
pubmed:dateCreated
1999-6-29
pubmed:abstractText
Treosulfan is a bifunctional alkylating cytostatic agent that has mainly been used in the therapy of advanced ovarian cancer. Lately, a growth inhibiting effect could be detected in human renal cell carcinoma-cell lines as well. In vitro, Treosulfan showed an even higher growth inhibition than Vinblastine.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0250-7005
pubmed:author
pubmed:issnType
Print
pubmed:volume
19
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1549-52
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed:articleTitle
Treosulfan in the treatment of metastatic renal cell carcinoma.
pubmed:affiliation
Department of Urology, University of Tubingen, Federal Republic of Germany.
pubmed:publicationType
Journal Article, Clinical Trial, Clinical Trial, Phase II